Morgan Stanley’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
307,701
-117,077
-28% -$364K ﹤0.01% 5185
2026
Q1
$968K Sell
424,778
-337,979
-44% -$778K ﹤0.01% 5159
2025
Q4
$2.14M Sell
762,757
-838,301
-52% -$3M ﹤0.01% 4760
2025
Q3
$7.69M Buy
1,601,058
+479,091
+43% +$3.05M ﹤0.01% 3787
2025
Q2
$10.2M Sell
1,121,967
-188,877
-14% -$1.39M ﹤0.01% 3425
2025
Q1
$11.8M Buy
1,310,844
+372,263
+40% +$3.93M ﹤0.01% 3190
2024
Q4
$12.3M Sell
938,581
-70,103
-7% -$934K ﹤0.01% 3236
2024
Q3
$15.8M Sell
1,008,684
-6,738
-0.7% -$102K ﹤0.01% 3028
2024
Q2
$13.7M Buy
1,015,422
+171,416
+20% +$3.51M ﹤0.01% 3059
2024
Q1
$23.4M Sell
844,006
-1,125,082
-57% -$25M ﹤0.01% 2525
2023
Q4
$37.9M Buy
1,969,088
+1,157,527
+143% +$21M ﹤0.01% 2736
2023
Q3
$13.1M Sell
811,561
-228,836
-22% -$4.06M ﹤0.01% 2868
2023
Q2
$19.8M Buy
1,040,397
+195,604
+23% +$3.49M ﹤0.01% 2483
2023
Q1
$12.3M Sell
844,793
-10,548
-1% -$189K ﹤0.01% 2943
2022
Q4
$16.7M Buy
855,341
+111,784
+15% +$2.18M ﹤0.01% 2527
2022
Q3
$17.9M Sell
743,557
-34,712
-4% -$1.07M ﹤0.01% 2311
2022
Q2
$24.5M Buy
778,269
+410,539
+112% +$14.9M ﹤0.01% 2060
2022
Q1
$16.2M Sell
367,730
-65,575
-15% -$2.82M ﹤0.01% 2353
2021
Q4
$18.9M Sell
433,305
-116,261
-21% -$4.56M ﹤0.01% 2224
2021
Q3
$17.2M Buy
549,566
+151,745
+38% +$5.97M ﹤0.01% 2253
2021
Q2
$16.8M Buy
397,821
+186,210
+88% +$7.24M ﹤0.01% 2346
2021
Q1
$7.95M Sell
211,611
-192,371
-48% -$6.02M ﹤0.01% 2893
2020
Q4
$10.9M Buy
403,982
+110,381
+38% +$2.84M ﹤0.01% 2415
2020
Q3
$7.37M Sell
293,601
-14,024
-5% -$205K ﹤0.01% 2327
2020
Q2
$2.34M Sell
307,625
-683,792
-69% -$5M ﹤0.01% 3449
2020
Q1
$9.07M Buy
991,417
+605,247
+157% +$3.65M ﹤0.01% 1873
2019
Q4
$2M Buy
386,170
+16,178
+4% +$104K ﹤0.01% 4041
2019
Q3
$2.15M Sell
369,992
-1,433,465
-79% -$6.43M ﹤0.01% 3717
2019
Q2
$5.77M Buy
1,803,457
+324,480
+22% +$1.11M ﹤0.01% 2777
2019
Q1
$6.06M Buy
1,478,977
+172,142
+13% +$1.09M ﹤0.01% 2529
2018
Q4
$8.27M Sell
1,306,835
-65,589
-5% -$681K ﹤0.01% 2328
2018
Q3
$22.7M Buy
1,372,424
+262,792
+24% +$4.47M 0.01% 1571
2018
Q2
$18.5M Buy
1,109,632
+625,218
+129% +$10.1M 0.01% 1708
2018
Q1
$7.53M Sell
484,414
-857,108
-64% -$15.3M ﹤0.01% 2623
2017
Q4
$25.3M Buy
1,341,522
+939,251
+233% +$20.8M 0.01% 1461
2017
Q3
$11.7M Sell
402,271
-82,995
-17% -$2.45M ﹤0.01% 2115
2017
Q2
$15.6M Buy
485,266
+89,559
+23% +$2.94M ﹤0.01% 1749
2017
Q1
$13.7M Sell
395,707
-84,393
-18% -$3.01M ﹤0.01% 1910
2016
Q4
$16.9M Buy
480,100
+252,150
+111% +$8.52M 0.01% 1691
2016
Q3
$7.92M Buy
227,950
+85,525
+60% +$2.99M ﹤0.01% 2223
2016
Q2
$5.32M Buy
142,425
+67,272
+90% +$2.53M ﹤0.01% 2557
2016
Q1
$3.04M Sell
75,153
-4,935
-6% -$184K ﹤0.01% 2977
2015
Q4
$2.88M Buy
80,088
+15,188
+23% +$549K ﹤0.01% 3177
2015
Q3
$2.07M Sell
64,900
-50,936
-44% -$1.73M ﹤0.01% 3475
2015
Q2
$3.94M Buy
115,836
+52,458
+83% +$1.77M ﹤0.01% 3005
2015
Q1
$2.15M Buy
63,378
+23,991
+61% +$836K ﹤0.01% 3547
2014
Q4
$1.38M Buy
39,387
+9,697
+33% +$327K ﹤0.01% 3877
2014
Q3
$972K Sell
29,690
-97,857
-77% -$3.33M ﹤0.01% 4054
2014
Q2
$4.33M Sell
127,547
-64,958
-34% -$2.23M ﹤0.01% 2783
2014
Q1
$6.74M Buy
192,505
+127,658
+197% +$4.5M ﹤0.01% 2302
2013
Q4
$2.37M Sell
64,847
-132,801
-67% -$4.87M ﹤0.01% 3256
2013
Q3
$6.84M Buy
197,648
+151,836
+331% +$5.31M ﹤0.01% 2126
2013
Q2
$1.55M Buy
+45,812
New +$1.52M ﹤0.01% 3352

Other funds holding ACH

Morgan Stanley's ACH Position: Q2 2026 in Review

Morgan Stanley reduced its Accendra Health (ACH) stake by 28% in Q2 2026, selling an estimated $364K and leaving 307,701 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #5185.

Morgan Stanley first reported a position in ACH in Q2 2013 and has held it in 53 quarters since. The position peaked at $37.9M in Q4 2023. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Morgan Stanley held 307,701 shares of Accendra Health worth $1.05M as of Q2 2026.
  • Morgan Stanley sold 117,077 Accendra Health shares in Q2 2026, an estimated $364K.
  • Accendra Health made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5185 holding.
  • Morgan Stanley first reported a position in Accendra Health in Q2 2013 and has held it in 53 quarters since.
  • Morgan Stanley's Accendra Health position peaked at $37.9M in Q4 2023.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.